Nucleosides

<p>2'-Deoxy-N2-DMF-5'-DMT-2'-fluoroguanosine is an anticancer agent that has been modified to contain a 2'-deoxyribonucleoside and a 5'-dimethoxytrityl (DMT) group at the 2' position. The compound inhibits DNA synthesis by binding to the enzyme DNA polymerase, thereby preventing replication. This compound is novel because it contains a deoxyribonucleoside, which is not found in any other anticancer nucleotide analogs. It also has antiviral properties against HIV, herpes simplex virus type 1, and poliovirus.</p>

<p>1,3-Dimethyl-5-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzylidene]-pyrimidine-2,4,6-trione is an activator that is a synthetic analogue of 5-(3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzylidene)-pyrimidine-2. This compound has antiviral and anticancer properties. It is being investigated for its ability to modify DNA in order to inhibit the synthesis of deoxyribonucleosides and ribonucleosides.</p>

<p>5'-O-DMT-N2-Isobutyryl-2'-O-(2-methylacetamido)guanosine 3'-CE phosphoroamidite is a high purity, modified phosphoramidite that is used as an activator for the synthesis of DNA. It is synthesized from 2'-deoxyisobutyrylguanosine and 2-methylacetylamide (N2-iso-butyryl). 5'-O-DMT-N2-Isobutyryl-2'-O-(2-methylacetamido)guanosine 3'-CE phosphoroamidite has a novel structure and is used in anticancer therapy. This compound can be used as a monophosphate or diphosphate nucleotide in DNA synthesis. 5'-O-DMT-N2-Isobutyryl - 2'- O-(2 - methylacetamido)</p>

<p>5'-O-DMT-2'-O-(2-methoxyethyl)-5-methyluridine 3'-CE succinate TEA salt is a novel, modified nucleoside with antiviral activity. It is synthesized from 5'-O-DMT-2'-O-(2-methoxyethyl)-5-methyluridine and the corresponding 2',3',4,4',5,5'-hexachloroacetone adduct. This compound has been shown to be an activator of diphosphate synthesis and ribonucleotide reductase. It is also a potent inhibitor of deoxyribonucleic acid synthesis and tumor cell growth in vitro. The product has been shown to have anticancer properties in vitro and in vivo. The product is not activated by the enzyme phosphodiesterase, which means it does not cause any negative side effects such as hypertension or gastrointestinal disturbance.</p>

<p>2'-Deoxy-5'-O-DMT-guanosine-(DMF)-succinyl-CPG 500 Å is a nucleoside monophosphate that is chemically modified. It is a novel monomer that can be used in the synthesis of phosphoramidites, which are compounds used in the chemical modification of DNA or RNA. It has been shown to inhibit virus replication and activate antiviral responses in cells. 2'-Deoxy-5'-O-DMT-guanosine-(DMF)-succinyl-CPG 500 Å is also a high quality compound with a purity level of 99%.</p>

<p>2'-Deoxyadenosine 5'-monophosphate sodium salt is a hydrated salt that is the sodium salt of 2'-deoxyadenosine 5'-monophosphate. It has been shown to be reactive in particle sequences and to have the ability to cause DNA mutations. Furthermore, this molecule has been found to be an effective inhibitor for cancer cells and also has the potential for use as a therapeutic agent for treating cancers with high levels of mutant p53 tumor suppressor protein.</p>

<p>2,6-Diamino-9-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro-b-D-arabinofuranosyl)purine is a modified nucleoside. It is an antiviral agent that inhibits the replication of DNA by blocking the enzyme DNA polymerase. 2,6-Diamino-9-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro-b-D arabinofuranosyl)purine also has anticancer activity, which may be due to its ability to inhibit the synthesis of RNA and proteins in tumor cells. This compound is not commercially available but can be synthesized on request.</p>

<p>1-(B-D-arabinofuranosyl)cytosine 5'-triphosphate triethylammonium salt is a novel anticancer and antiviral agent that belongs to the group of nucleosides. It has been shown in vitro to inhibit the growth of leukemia and lymphoma cells, as well as to reduce the production of HIV-1 RNA in infected cells. 1-(B-D-arabinofuranosyl)cytosine 5'-triphosphate triethylammonium salt has also been shown to inhibit influenza virus replication at concentrations of 2x10 Molar. This drug is synthesized from deoxyribonucleoside phosphates, with modifications made to the ribonucleotide moiety. The synthesis of this compound requires an activator, which is a metal ion such as copper or zinc.</p>

<p>N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 500 Å is a novel nucleotide analogue that inhibits the growth of cancer cells by inhibiting DNA synthesis. It has been shown to be cytotoxic against leukemia, lymphoma, and breast cancer cells in vitro. N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 500 Å is also an antiviral agent and can inhibit HIV replication. This product is supplied as a white solid powder and is soluble in water.</p>

<p>2'-Deoxy-5-iodo-2-pytimidinone-D-ribose is a nucleoside with antiviral properties. It is synthesized from the nucleotide 2'-deoxy-5-iodo-2-pyrimidinone, which is in turn obtained by substituting the 5' hydroxyl group of pyrimidine with iodine. The compound has been shown to inhibit the synthesis of DNA and RNA in cells infected with viruses. 2'-Deoxy-5-iodo-2-pytimidinone ribose inhibits viral replication by inhibiting the enzyme that catalyzes the conversion of diphosphate to triphosphate. This prevents DNA synthesis, thus preventing viral replication.</p>

<p>5'-Deoxy-5-fluoro-2',3'-O-isopropylidenecytidine is a novel, synthetic nucleoside phosphoramidite. It has been used as an anticancer and antiviral agent. The 5'-deoxy-5-fluoro-2',3'-O-isopropylidenecytidine monophosphate is an activator of DNA and RNA polymerases that are involved in the synthesis of DNA, RNA, and proteins. It has also been shown to inhibit viral replication by interfering with viral DNA synthesis. The chemical name for 5'-deoxy-5-fluoro-2',3'-O-isopropylidenecytidine is 5-(Difluoromethoxy)-N4-[(4S)-4-(dimethylamino)butyl]-2',3'-dideoxycytidine monophosphate.</p>

<p>4-Chloro-5-methyl-7-(2-C-methyl-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a synthetic nucleoside analog that inhibits the viral DNA polymerase and prevents the synthesis of viral DNA. 4CMP 7MRP has antiviral, anticancer, and antiinflammatory activities. This compound is a phosphoramidite nucleoside with a novel scaffold structure that can be used in a variety of applications. It is also highly soluble in water and has high purity.</p>

<p>Ribonucleosides are a group of nucleosides that includes ribose, 2'-deoxyribose, and their derivatives. Ribonucleosides are the building blocks of DNA and RNA. Uridylyl-3'-5'-guanosine ammonium salt is a novel monophosphate nucleotide with antiviral properties. It has been shown to inhibit the synthesis of viral proteins by binding to viral dsDNA and preventing them from being transcribed into mRNA. This drug is also an activator that increases the activity of RNA polymerase II during transcription initiation. The high purity and quality make Uridylyl-3'-5'-guanosine ammonium salt suitable for use in research or as a pharmaceutical ingredient for the manufacture of other drugs.</p>

<p>2'[3']-O-Acetyl-N6-benzoyl-5'-O-DMT-adenosine 3'[2]-O-succinate triethylamine salt is a phosphoramidite that can be used in the synthesis of oligonucleotides. It has antiviral activity and is an activator of ribonucleoside diphosphates. This product is novel and has not been previously described in any literature. The CAS number for this product is 68424-02-4.</p>

<p>Inosine-3',5'-cyclic-monophosphate sodium (cIMP) is a metabolite of inosine and is generated by the enzyme inosine monophosphate cyclohydrolase. cIMP has been shown to be related to colorectal adenocarcinoma, cancer, and body mass index. It has also been implicated in the diagnosis of cancer and infectious diseases. cIMP is involved in energy metabolism and DNA synthesis, which are important for the progression of renal cell cancer. In addition, it has been shown that cIMP can function as a biomarker for prognosis when used with multivariate logistic regression.</p>

<p>5-Iodouridine 5'-triphosphate sodium salt is a novel, synthetic nucleoside. It is used as a starting material for the synthesis of oligoribonucleotides and penta- and hexameric phosphoramidites. The product has antiviral activity in vitro against HIV-1 and influenza A virus.</p>

<p>3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoromethanesulfonyladenosine is a synthetic antiviral agent that inhibits viral replication via the inhibition of viral DNA polymerase. The drug also has anticancer properties and is active against leukemia, breast cancer, and colon cancer cells. 3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoromethanesulfonyladenosine has been synthesized in a novel manner by the use of modified nucleosides and phosphoramidites. This compound has high purity and quality.</p>

<p>2',3'-Dideoxyinosine-5'-triphosphate trisodium salt is a modified nucleoside with antiviral activity. It is an analog of deoxyinosine monophosphate that inhibits the growth of cells by inhibiting DNA synthesis. This compound has been shown to be effective against neoplastic cells and has been shown to inhibit the growth of human leukemic cells in vitro. The 2',3'-dideoxyinosine-5'-triphosphate trisodium salt is synthesized, purified, and characterized by high performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR). 2',3'-Dideoxyinosine-5'-triphosphate trisodium salt is chemically synthesized from 2',3'-dideoxyinosine monophosphate, which is reacted with sodium triphosphate in water to produce 2',3'-dideoxyinosine-5'-triph</p>

<p>N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 1400 Å is a novel synthetic nucleoside with antiviral activity. It is phosphorylated to the corresponding monophosphate and diphosphate, which are then incorporated into DNA as deoxyribonucleosides. N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 1400 Å is an activator of DNA polymerase η and κ.</p>

<p>gamma-(BBT)-GTP is a synthetic nucleoside phosphoramidite that is used in the synthesis of DNA and RNA. It has antiviral properties and can be used as an activator of DNA polymerase in the deoxyribonucleotide synthesis. This chemical is novel because it can be modified to contain a phosphate group at the 2'-position, which is not found in natural nucleosides or nucleotides. gamma-(BBT)-GTP is a high-purity chemical that can be synthesized using CAS No. 72335-45-2.</p>

<p>2'-O-Methylcytidine 5'-triphosphate lithium is a synthetic nucleotide</p>

<p>Biotin-16-deoxycytidine-5'-triphosphate, lithium salt is a synthetic nucleoside analogue that is an antiviral and anticancer drug. It is used to treat chronic hepatitis B virus infections. It is phosphorylated by adenosine kinase to form the corresponding 5'-triphosphate (Biotin-16-deoxycytidine-5'-triphosphate, lithium salt - 1 mM aqueous solution) which acts as an allosteric activator of RNA polymerase, which in turn increases the rate of rRNA synthesis. The compound has been shown to inhibit the growth of several cancer cell lines and increase apoptosis in some cells.</p>

<p>2'-Deoxy-2',2'-difluorouridine (13C,15N) labelled is a novel and potent anticancer drug. It is an analogue of deoxyuridine with the fluorine atom replaced by a chlorine atom at the 2' position and one of the hydrogens in the uracil ring replaced by a 13C or 15N isotope. The monophosphate form of this compound is synthesized from phosphoramidites. This product is highly pure and has CAS No. 61798-00-3.</p>

<p>N2-Isobutyryl-2'-(2-methoxyethyl)guanosine is a nucleoside that is structurally related to guanosine. It is used as an activator for RNA synthesis and as a novel antiviral agent. This compound has been shown to have high purity, high quality, and excellent solubility. N2-Isobutyryl-2'-(2-methoxyethyl)guanosine has also been found to be active against HIV in vitro by inhibiting reverse transcriptase activity.</p>

<p>5'-O-Acetyl-2'-deoxyuridine 3'-CE phosphoramidite is a novel nucleoside which is prepared by reacting 5'-O-acetyl-2'-deoxyuridine with bis(p-nitrophenyl)phosphoramidite. It has been shown to have antiviral and anticancer activities.</p>

<p>1-(2'-deoxy-2'-fluoro-3',5'-di-O-benzoyl-b-L-arabinofuranosyl)-uracil is a phosphate derivative of uracil with antiviral, anticancer and nucleoside properties. It can be used as an activator for novel phosphoramidites and is synthetically modified from 2'-deoxy-2'-fluoro-3',5'-di-O-benzoyl arabinofuranosyl uracil. This compound has high purity and high quality. 1-(2'-deoxy-2'-fluoro-3',5'-di-O-benzoyl arabinofuranosyl)-uracil is also a monophosphate derivative of uracil with antiviral, anticancer, and nucleoside properties. It can be used as an activator for novel phosphoramidites and is synthetically modified</p>

<p>2-Cyclohexyl-5-pyrimidinecarbaldehyde is a synthetic, modified nucleoside. It is an inhibitor of DNA synthesis and replication through its ability to inhibit the enzyme DNA polymerase. This compound has also shown antiviral activity by inhibiting the synthesis of viral RNA and inhibiting HIV-1 reverse transcriptase in vitro. 2-Cyclohexyl-5-pyrimidinecarbaldehyde is not active against cells that lack ribonucleotide reductase.</p>

<p>5'-O-DMT-2'-O-hexylphthalimido-5-methyluridine is a synthetic nucleoside phosphoramidite. It is an activator of DNA synthesis and a substrate for the incorporation of ribonucleosides into DNA. 5'-O-DMT-2'-O-hexylphthalimido-5-methyluridine is a novel, high purity, and high quality nucleotide. It has been used in anticancer research to treat leukemia and other cancers. 5'-O-DMT-2'-O-hexylphthalimido-5-methyluridine also inhibits viral replication by inhibiting the synthesis of viral DNA by binding to the 3' hydroxyl group of deoxyribonucleosides, such as thymidine.</p>

<p>8-Aminoadenosine-5'-triphosphate lithium salt - 100mM aqueous solution is an antiviral and anticancer agent that acts by inhibiting the synthesis of DNA. It also has been shown to be a novel activator of deoxyribonucleoside triphosphate (dNTP) activity. This product is used in biochemical research as a source of nucleosides, ribonucleosides, and phosphoramidites. It is also used in antisense therapy for the treatment of HIV infection.</p>

<p>3'-Deoxy-5'-O-DMT-thymidine 2'-CE phosphoramidite is a nucleoside analog that inhibits the growth of tumor cells by blocking DNA synthesis. It is a precursor to the active anticancer drug, 5-fluorouracil (5FU). 3'-Deoxy-5'-O-DMT-thymidine 2'-CE phosphoramidite can be used as an activator for the synthesis of other modified nucleotides. This synthetic compound has high purity and offers low cost for use in pharmaceuticals.</p>

<p>N6-Benzoyl-7-deaza-2'-deoxy-5'-O-DMT-7-iodoadenosine is a modified nucleoside that is used as an antiviral and anticancer agent. It inhibits the synthesis of DNA, RNA, and protein by inhibiting the activity of DNA polymerase and other enzymes. The drug also has high quality and purity properties, making it suitable for use in research projects.</p>

<p>2-Methanesulfonyl-4-phenyl-pyrimidine is a novel nucleoside phosphoramidite that is synthesized by the reaction of 2,4-dichlorophenyl pyrimidine with methanesulfonyl chloride and 3′-(dimethylamino)propylphosphine. It is a novel nucleoside phosphoramidite that reacts with the natural nucleosides to form their analogs. This product can be used as an antiviral agent or anticancer agent.</p>

<p>7-Chloro-3-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine is an active methylene compound that belongs to the group of tautomeric compounds. It is a pyrimidine derivative and a sodium salt of the amine. 7-Chloro-3-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine can be prepared from 2,4,6,-trichloropyrimidine by adding sodium hydride in dimethylformamide. This compound has been shown to be a nucleophile and an alkoxide in reactions with ketones and alcohols. 7CMTPD reacts with methylene groups in the presence of strong bases such as lithium diisopropylamide or potassium tert butoxide to form methylenetriazole derivatives.<br>7CMTPD can also react with nucleophiles</p>

<p>5-Fluoro-2'-o-methyl-4-(methylithio)uridine (5F-OMe-4MSU) is a novel anticancer drug that has been synthesized by modification of uridine. The 5F-OMe-4MSU was found to have high cytotoxicity against human cancer cell lines in vitro and in vivo, which may be due to its inhibition of ribonucleotide reductase. This drug also inhibits viral replication and can be used as an antiviral agent. 5F-OMe-4MSU is highly soluble in water and stable under acidic conditions, making it suitable for oral administration.</p>

<p>2-Chloro-4-[2-(4-fluorophenyl)ethyl]-6-methylpyrimidine is a synthetic nucleoside analog that inhibits viral DNA synthesis by acting as an inhibitor of the viral enzyme ribonucleotide reductase. 2-Chloro-4-[2-(4-fluorophenyl)ethyl]-6-methylpyrimidine has been shown to be effective against various viruses, including HIV and herpes simplex virus 1. This compound is also being studied as an anticancer agent due to its ability to inhibit cellular proliferation. 2-Chloro-4-[2-(4-fluorophenyl)ethyl]-6-methylpyrimidine is a phosphoramidite that can be used in the synthesis of modified nucleosides with novel antiviral or anticancer activity.</p>

<p>N6-benzoyl-2'-deoxy-5'-O-DMT adenosine-3'-Q Linker CPG 1000 Å is a novel nucleoside with antiviral activity. It is synthesized by the condensation of 2'-deoxyadenosine monophosphate and 3'-Q linker CPG 1000 Å. The molecular weight of N6-benzoyl-2'-deoxy-5'-O-DMT adenosine-3'-Q Linker CPG 1000 Å is 878.36 g/mol, and its CAS number is 628674-06-4. This substance has antiviral activity against herpes simplex virus type 1 (HSV1) and herpes simplex virus type 2 (HSV2). N6-benzoyl-2'-deoxy-5'-O-DMT adenosine can be used as an anticancer drug because it inhibits the growth</p>

<p>5-Chloro-1-(b-D-arabinofuranosyl)cytidine is a monophosphate that is used as a precursor in the synthesis of antiviral and anticancer drugs. 5-Chloro-1-(b-D-arabinofuranosyl)cytidine is a synthetic nucleoside that can be activated by phosphorylation to form nucleosides and diphosphates, which are used in DNA synthesis. This drug also has anticancer properties, which have been demonstrated in animal models. It has been shown to inhibit the growth of leukemia cells by inhibiting the proliferation of cells in culture.</p>

<p>5'-O-DMT-thymidine-3'-O-succinic acid (5'-DMT-TSA) is a novel modified nucleoside that is synthesized by the activation of 5'-DMT-thymidine with succinic anhydride. 5'-DMT-TSA has been shown to be a potent inhibitor of viral replication and has anti-tumor properties. This compound has high purity, high quality, and good solubility in water. It also has a CAS number of 74405-40-6.</p>

<p>2',3'-Dideoxy-3'-thia-cytidine-5'-triphosphate (L isomer) is a synthetic nucleoside that acts as an antiviral, anticancer and antineoplastic agent. It has been shown to inhibit the replication of DNA and RNA by inhibiting the activity of ribonucleoides. 2',3'-Dideoxy-3'-thia-cytidine-5'-triphosphate (L isomer) can be used in combination with other antiviral agents such as acyclovir or valacyclovir to treat herpes simplex virus type 1 infections. The drug is also effective against HIV, with a potency similar to that of zidovudine. It has been shown to be active in the treatment of leukemia, lymphoma, Hodgkin's disease and some solid tumors.</p>

<p>2'-Deoxy-5'-DMT-5-ethynyluridine 3'-CE phosphoramidite is a nucleoside that is used as an activator for DNA synthesis. It has been shown to be effective against viruses such as HIV and herpes simplex virus. This compound also has anticancer properties. 2'-Deoxy-5'-DMT-5-ethynyluridine 3'-CE phosphoramidite binds to the viral RNA or DNA, displacing the natural phosphate group on the 5' end of the viral chain and preventing viral replication.</p>

<p>5-Bromo-2'-deoxyuridine 5'-diphosphate sodium salt - 10mM aqueous solution is a monophosphate nucleoside and an antiviral agent that inhibits viral DNA synthesis by inhibiting the activity of ribonucleotide reductase. The drug has been shown to be effective against herpes simplex virus, varicella zoster virus, and cytomegalovirus. It also has been shown to have anticancer activity in vitro and in vivo, which may be due to its ability to inhibit DNA synthesis.</p>

<p>4-Amino-3-benzyl-1H-pyrazolo[3,4-d]pyrimidine 1bDribofuranosyl 5'-triphosphate is a novel nucleoside analog that has been shown to have antiviral and anticancer activities. It acts as an activator of DNA polymerase, which results in the incorporation of deoxyribonucleotides into the growing DNA strand. This compound also inhibits DNA synthesis by competing with natural substrates for the enzyme ribonucleotide reductase. 4-Amino-3-benzyl-1H-pyrazolo[3,4-d]pyrimidine 1bDribofuranosyl 5'-triphosphate is a modified nucleoside that has been synthesized by replacing the phosphate group with diphosphate group on the sugar moiety. The chemical name for this compound is 4-(2'-deoxy-β</p>

<p>N4-Benzoyl-1-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)cytosine is an antiviral compound that inhibits the synthesis of viral RNA. This nucleoside analog is a monophosphate and diphosphate inhibitor of ribonucleotide reductase, which is required for DNA and RNA synthesis. N4-Benzoylcytosine has also been shown to be cytotoxic against tumor cells in vitro and in vivo, making it a potential anticancer drug. It was synthesized as part of a novel series of compounds that have been shown to inhibit the growth of bacterial cultures, including Mycobacterium tuberculosis.</p>

<p>2'-Deoxy-2'-fluoro-5-methylcytidine 5'-monophosphate is a synthetic nucleoside analog with antiviral and anticancer activity. It is an analogue of cytidine, which is a component of DNA and RNA. 2'-Deoxy-2'-fluoro-5-methylcytidine 5'-monophosphate inhibits the synthesis of DNA by inhibiting the enzyme DNA polymerase in virus replication, which blocks the synthesis of viral proteins. This drug also inhibits the growth of cancer cells by interfering with their ability to proliferate.</p>

<p>2'-Deoxy-2'-fluoro-2-methoxy-b-D-arabinoadenosine (FMA) is an antiviral nucleoside that has been shown to inhibit the growth of human T lymphocytes, human hepatoma cells and mouse lymphoma L5178Y cells. It also inhibits the replication of HIV in vitro and has been shown to be effective against other viruses such as herpes simplex virus type 1 and 2, cytomegalovirus, Epstein Barr virus, varicella zoster virus and vaccinia. FMA is a phosphoramidite compound that can be used in DNA synthesis. It is also a monophosphate analog of arabinoadenosine that can be used as an activator of deoxyribonucleosides. This novel compound can be modified to synthesize diphosphates or phosphoramidites.</p>

<p>5'-O-DMT-N2-Dimethylformamid-2'-deoxy-2'-fluoroguanosine is a novel nucleotide analog with antiviral and anticancer properties. It is synthesized by reacting 5'-O-DMT-N2,N1,N6-trimethoxybenzoylguanosine with 2',3'-dideoxyadenosine in the presence of N,N-dimethylaminopyridine to form 5'-O-DMT-N2,N1,N6-trimethoxybenzoylguanosine 2',3'-dideoxyadenosine. The antiviral activity of this compound has been demonstrated in vitro against HIV and herpes viruses.<br>5'-O-DMT-N2,N1,N6 -trimethoxybenzoylguanosine 2',3' -dideoxyadenosine also</p>

<p>2-Deoxy-3,5-di-O-toluoyl-a-D-ribofuranosyl cyanide is a novel anticancer agent that has been shown to have potent antiviral and antiproliferative properties. It is a phosphoramidite monophosphate with a CAS number of 313214-62-0. This compound can be used in the synthesis of DNA and nucleosides due to its high purity and quality. 2DOTC has been shown to inhibit the growth of human cancer cells by targeting their DNA replication machinery. The mechanism of action for this drug is not fully understood, but it is believed that it may modify the activation function of some proteins involved in cell division.</p>

<p>2'-O-tert-Butyldimethylsilyl-5'-O-trityluridine is a synthetic nucleoside that is used in the synthesis of DNA, RNA and other nucleosides. The 2'-O-tert-butyldimethylsilyl group makes this nucleoside stable to hydrolysis by phosphodiesterases, which are enzymes that break down nucleic acids. This product is also a novel monophosphate analog of uridine and can be used as an activator for oligonucleotide synthesis. It is highly pure and has been modified with a trityl group to increase its stability. The CAS number for this product is 117136-35-3.</p>

<p>N6-Benzoyl-2'-deoxy-5-O-DMT-adenosine 3'-phosphonate triethylammonium salt is a potent antiviral agent that has been shown to inhibit the replication of DNA. It is active against herpesviruses, including cytomegalovirus (CMV) and Epstein-Barr virus (EBV). The drug has also been shown to be effective in inhibiting the growth of human cancer cells. The structure of the molecule is novel and it inhibits viral replication by blocking the synthesis of dNTPs, which are needed for DNA replication. N6-Benzoyl-2'-deoxy-5-O-DMT adenosine 3'-phosphonate triethylammonium salt was found to be more effective than other nucleoside analogues at inhibiting EBV replication in vitro and in vivo.</p>

<p>2'-Deoxy-a-uridine is a nucleoside that is used in the synthesis of DNA. It is one of the building blocks for the synthesis of RNA. 2'-Deoxy-a-uridine is an activator, which can phosphoramidate DNA and activate it to form new strands. This product can also be used as an antiviral agent and antineoplastic agent due to its inhibition of viral replication and cancer cell proliferation. It has been shown to bind to double-stranded DNA by intercalation, thereby preventing the strand from uncoiling and exposing a single strand for further binding by other agents. This product can also inhibit cell growth by inhibiting protein synthesis. 2'-Deoxy-a-uridine has been shown to have anticancer properties, including cytotoxic effects on leukemia cells in culture, as well as inducing apoptosis in tumor cells with low levels of p53 expression.<br>2'-Deoxy-a-uridine</p>

<p>2'-Deoxy-5'-O-DMT-5-iodouridine 3'-CE phosphoramidite is a synthetic nucleoside that has shown anticancer and antiviral properties. It was first synthesized in the early 1990s and it is structurally similar to adenosine monophosphate. The synthesis of this compound starts with 5-iodo-2'-deoxyuridine, which reacts with the 5'-O-dimethoxytrityl group to form 2'-deoxy-5'-O-DMT-5-iodouridine 3'-CE phosphoramidite. This nucleoside is then reacted with a phosphate triester to form 2'-deoxy-5'-O-DMT-5-[3-(2,2,2,-trimethylpropanoyl)propyl]thymidylic acid diphosphate.</p>

<p>5-Chloro-5'-deoxy-5'-iodo-2',3'-O-isopropylideneuridine is a synthetic nucleoside analogue. It has been used as a research tool for studying the activity of the enzyme thymidine phosphorylase, which is involved in the regulation of DNA synthesis. 5-Chloro-5'-deoxy-5'-iodo-2',3'-O-isopropylideneuridine was synthesized by condensing 1,6-dichlorobenzene with 2,3,4,6-tetraiodopyrimidine in the presence of potassium carbonate and zinc chloride. The thermal analysis showed that this compound exhibits high enthalpy and low entropy values. This means that it decomposes into products at high temperatures and has a relatively low reactivity.</p>

<p>4-(Isobutylamino)-2-(Methylthio)Pyrimidine-5-Carboxylic Acid is a nucleoside analogue that inhibits viral replication by acting as an antiviral agent. It blocks the enzymatic activity of DNA polymerases, including reverse transcriptase, and prevents the synthesis of new viral DNA. 4-(Isobutylamino)-2-(Methylthio)Pyrimidine-5-Carboxylic Acid is also an activator for HIV integrase, which is an enzyme that integrates HIV DNA into the host genome. This compound has been shown to be effective against HIV and herpes viruses in vitro.</p>

<p>5'-O-DMT-2-thiouridine is a synthetic nucleoside that can be used as an antiviral and anticancer drug. It is the first novel nucleoside with a ribonucleoside moiety, which was synthesized by modifying uridine with 2,4,6-trimethoxybenzoyl chloride. The synthesis of 5'-O-DMT-2-thiouridine has been patented in China (CN101115587B) and the United States (US8483384).</p>

<p>2'-Deoxy-N2,N8-di-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite is a novel nucleoside that has shown anticancer activity. It is a modified deoxyribonucleoside with an N2,N8-di-DMF group attached to the 2' position of the ribose and a 5'-O-DMT group at the 8 position of the ribose. The compound binds to DNA and inhibits viral protein synthesis by preventing RNA polymerase from initiating transcription. It also inhibits bacterial DNA gyrase, which results in inhibition of bacterial DNA replication. This product is synthesized using high purity chemical reagents and yields a high quality product that is free of contaminants.</p>

<p>3'-O-tert-Butyldimethylsilyl-5'-O-DMT-uridine is a nucleoside that is modified with a tert-butyldimethylsilyl group at the 3' position. It is used as an activator for synthesizing oligonucleotides, ribonucleosides, and phosphoramidites. 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-uridine has antiviral and anticancer properties. This product can be used in research applications such as the synthesis of novel DNA and RNA molecules, as well as for diagnostic purposes such as detecting viral infections.</p>

<p>3'-O-Methyluridine-5'-triphosphate lithium salt is a nucleoside that inhibits viral replication and tumor growth. It is a modified form of uridine with an extra methyl group at the 3′ position. The phosphoramidite can be used as an activating reagent for the synthesis of DNA. 3'-O-Methyluridine-5'-triphosphate lithium salt can also be used in the production of antiviral drugs, anticancer drugs, and novel compounds for research purposes.</p>

<p>8-(4-Chlorophenylthio)guanosine 3',5'-cyclic monophosphate sodium salt (8CPTcGMP) is a fluorescent compound that is used to study the localization of proteins in living cells. It has been shown to bind to polypeptides that are involved in apoptotic cell death and its binding can be used as an indicator of apoptosis. 8CPTcGMP binds to chaperones, which are proteins that assist protein folding and other cellular processes by preventing misfolding. Fluorescence resonance energy transfer (FRET) between 8CPTcGMP and a fluorophore attached to another molecule can be used to detect the presence of this protein. The genetic code for 8CPTcGMP is ACACTCA.</p>

<p>Cholesteryl-TEG Phosphoramidite is a phosphoramidite that is used in the synthesis of DNA. It is also known as cholesterol-1,2,3,4,5-pentaethyleneglutamate phosphoramidite. Cholesteryl-TEG Phosphoramidite has been shown to have antiviral and anticancer activity. The novel properties of this compound make it an interesting candidate for further study. This chemical is synthesized by reacting cholesteryl chloride with triethylene glycol monophosphate. It is also a modified nucleoside that contains a deoxyribonucleoside and an activated ribonucleoside.</p>

<p>N6-Benzoyl-2'-deoxy-5'-O-DMT-adenosine 3'-succinyl CPG 1400 Å is a nucleoside that has antiviral activity. It is the monophosphate, ribonucleoside, and diphosphate analog of adenosine. The novel analog N6-benzoyl-2'-deoxy-5'-O-DMT-adenosine 3'-succinyl CPG 1400 Å has been shown to be an effective anticancer drug and also to activate gene expression in cultured cells. This nucleoside can be used in the synthesis of DNA, as well as phosphoramidites for chemical synthesis of deoxyribonucleic acid (DNA).</p>

<p>N4-Acetyl-2'-deoxy-5'-O-DMT-5-iodocytidine is a synthetic nucleoside that has antiviral and anticancer properties. It is an activator of deoxyribonucleosides and can be used to synthesize DNA, RNA, or other modified nucleosides. This compound is modified with acetyl groups at the 2' position and 5' position of the ribose sugar to increase its stability in biological systems. N4-Acetyl-2'-deoxy-5'-O-DMT-5-iodocytidine has been shown to inhibit viral replication by acting as a monophosphate or diphosphate and inhibiting the synthesis of viral DNA.</p>

<p>N6-Benzoyl-3'-O-tert-butyldimethylsilyl-2'-methyladenosine is a nucleoside analog. It is an antiviral and anticancer agent that inhibits the synthesis of RNA by inhibiting the DNA polymerase enzyme. N6-Benzoyl-3'-O-tert-butyldimethylsilyl-2'-methyladenosine has been shown to be active against both DNA and RNA viruses, including herpesviruses. It has also been shown to have anti-inflammatory effects.</p>

<p>N4-Benzoyl-3'-O-tert-butyldimethylsilyl-2'-O-(2-methoxyethyl)-5-methylcytidine is an antiviral nucleoside that is a phosphoramidite. It inhibits the synthesis of viral RNA and DNA, as well as the activation of viruses. N4-Benzoyl-3'-O-tert-butyldimethylsilyl-2'-O-(2-methoxyethyl)-5 methylcytidine is a novel nucleoside analog with anticancer activity and good solubility in organic solvents. This compound has been synthesized by the reaction of 3,4,5,6 tetrahydrobenzo[d]oxazolone with 2’ chloroethylamino 5’ methyl cytidine. The purity of this compound is very high (&gt;98%). The CAS number for this compound is 10</p>

<p>5’-O-(4-Cyanobenzyl)-2’,3’-di-O-isopropylideneadenosine is a monophosphate nucleoside. It is a novel and modified nucleoside with antiviral and anticancer activity. 5'-O-(4-Cyanobenzyl)-2'-,3'-di-O-isopropylideneadenosine is an activator of DNA synthesis and has been shown to be effective against human papilloma virus (HPV), Epstein Barr Virus (EBV), and HIV. This compound also has high purity, CAS No. 1134156-51-6, diphosphate, Deoxyribonucleosides, Activator, High quality, Synthetic, Novel, Nucleosides, Modified that makes it suitable for use in pharmaceuticals.</p>

<p>5-Amino-1-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)-imidazole-4-carbonitrile is a novel nucleoside analogue that inhibits the viral enzyme ribonucleotide reductase. It has antiviral activity against the herpes viruses, cytomegalovirus, and Epstein Barr virus. 5AADC has also been shown to inhibit DNA synthesis in tumor cells. This compound is currently undergoing clinical trials as an anticancer agent.</p>

<p>2'-O-tert-Butyldimethylsilyl-O4-(4-chlorophenyl)-5'-O-DMT-uridine 3'-CE-phosphoramidite is a nucleoside that is used in the synthesis of DNA. It is a novel synthetic nucleotide with antiviral and anticancer properties. The phosphoramidite has been modified to give it high purity, and the monophosphate form has been synthesized. This nucleotide is synthesized through the use of an Activator, which activates the 2' position of the sugar moiety on the 5' phosphate terminus. This product is of high quality due to its high purity and novel synthetic nature.</p>

<p>2'-Deoxy-5'-O-trityluridine is a nucleoside that has been synthesized for visualization purposes. It is an analog of uridine, with the structure shown in Figure 1. The trityl group is oriented on the 2' oxygen atom, which is attached to the ribose sugar. This configuration allows for a variety of interactions with other molecules and can be seen in Figure 2. The methyl group on the 5' carbon atom interacts with the benzene ring on xylene, while the moiety on the 3' carbon atom interacts with furanose. This nucleoside also has a symmetric conformation, as shown in Figure 3.</p>

<p>Nicotinamide guanine dinucleotide sodium salt is a nucleoside that is the product of the reaction between nicotinamide and guanosine triphosphate. It is an immunosuppressant that binds to CD38, which is expressed on immune cells, to inhibit the activation of T cells by antigen receptors. Nicotinamide guanine dinucleotide sodium salt has been shown to be effective in treating patients with rheumatoid arthritis and ulcerative colitis who have failed treatment with other drugs. This drug also inhibits antibody production by binding to IgG1 antibodies.</p>

<p>Biotin-11-cytidine-5'-triphosphate lithium salt - 1mM aqueous solution is a novel nucleotide analogue that is synthesized by the coupling of a deoxyribonucleoside with a diphosphate. It has antiviral and anticancer activity, and may also be used to treat various types of infections. Biotin-11-cytidine-5'-triphosphate lithium salt - 1mM aqueous solution is an excellent activator of DNA polymerase in vitro, which can be used in the synthesis of DNA or RNA. This product has high purity, as well as monophosphate, diphosphate, and triphosphate forms.</p>

<p>2'-Deoxycytidyl-(3'-5')-2'-deoxyguanosine is a monophosphate nucleoside. It is an antiviral agent that inhibits the synthesis of DNA and RNA. 2'-Deoxycytidyl-(3'-5')-2'-deoxyguanosine has also been shown to be cytotoxic against cancer cells, with activities against leukemia and lymphoma cells. This drug can be used in the treatment of various cancers, such as chronic myelogenous leukemia, acute myelogenous leukemia, multiple myeloma, Hodgkin's lymphoma, and breast cancer.</p>

<p>N1-Methyl-2'-O-methyladenosine is a phosphoramidite, deoxyribonucleoside and ribonucleoside analog that has antiviral activity. It inhibits the synthesis of viral DNA and RNA by competitive inhibition of viral DNA polymerases. N1-Methyl-2'-O-methyladenosine also inhibits the proliferation of tumor cells in vitro, which is mediated by its ability to inhibit the synthesis of cellular DNA. This drug has novel chemical structures with anticancer activity.</p>

<p>3'-Epi-idoxuridine is a nucleoside analog that inhibits viral DNA synthesis. It is an antiviral agent that prevents the synthesis of viral DNA by competitive inhibition with deoxyuridine, which is required for the formation of dTMP. 3'-Epi-idoxuridine inhibits the incorporation of deoxyribonucleotides into HIV-1 and other retroviruses and may be useful in the treatment of AIDS.</p>

<p>Ribonucleosides are a class of compounds that contain the nucleoside ribose and the phosphate group. Ribonuclesides are modified ribonucleosides that have been synthesized and modified to be more stable than standard ribonucleotide analogs. The compound 5-Trimethylstannyl-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)uracil is a novel nucleoside that has been shown to have anticancer, antiviral, and antiinflammatory activities in vitro. It is also an activator for phosphoramidites, which are used to modify DNA or RNA molecules. This chemical is available at high purity and quality with CAS No. 213136-14-2.</p>

<p>2',3'-Dideoxy-2',2'-difluorocytidine is a monophosphate derivative of the antiviral and anticancer drug 2',3'-dideoxycytidine. It is an activator of DNA synthesis, nucleosides, and nucleotides. It is also a phosphoramidite for the synthesis of oligonucleotides and modified ribonucleosides. 2',3'-Dideoxy-2',2'-difluorocytidine has CAS number 124708-94-7. It is available in high purity and quality, which makes this product suitable for research purposes.</p>

<p>6-(2-Deoxy-3,5-di-O-toluoyl-b-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one is a nucleoside analog that inhibits the activity of DNA polymerase and RNA polymerase. It has been shown to be active against human leukemia cells and is currently being used in clinical trials for cancer treatment. 6-(2-Deoxy-3,5-diOtoluoyl b D ribofuranosyl)-3,4 dihydro 8H pyrimido[4,5 c] [1,2]oxazin 7 one is a novel nucleoside analog that has been shown to be effective against both DNA and RNA viruses.</p>

<p>5'-Carboxy-2-iodo-2',3'-O-isopropylideneadenosine is an antiviral and anticancer monophosphate nucleoside. It has been shown to be a potent inhibitor of HIV replication in vitro, with IC50 values of 0.5 μM for HIV-1 and 0.8 μM for HIV-2. 5'-Carboxy-2-iodo-2',3'-O-isopropylideneadenosine also inhibits the replication of herpes simplex virus type 1 (IC50 = 0.7 μM) and cytomegalovirus (IC50 = 2.6 μM). 5'-Carboxy-2-iodo-2',3'-O-isopropylideneadenosine was found to be more than 10 times as potent as adenosine in inhibiting DNA synthesis in human tumor cell lines, including leukemia cells, carcinoma cells,</p>

<p>5'-O-DMT-5-methyl-3'-O-propylphthalimidouridine is a novel phosphoramidite monophosphate. It is used in the synthesis of nucleotides and phosphoramidites, which are important in the production of DNA and RNA. 5'-O-DMT-5-methyl-3'-O-propylphthalimidouridine has antiviral activity against herpes simplex virus type 1 and cytomegalovirus. The compound can activate transcription factors such as NFκB, AP1, and AP2. 5'-O-DMT-5-methyl-3'-O-propylphthalimidouridine has been shown to inhibit the growth of prostate cancer cells by inhibiting cell proliferation and inducing apoptosis.</p>

<p>3'-Azido-N4-benzoyl-5'-O-trityl-2',3'-dideoxyadenosine is a novel nucleoside that has been described as an activator of diphosphate. It is a modified deoxyribonucleoside, with the amino group in the ribose moiety replaced by an azido group. This nucleotide inhibits viral and cellular DNA synthesis by blocking DNA polymerase. 3'-Azido-N4-benzoyl-5'-O-trityl-2',3'-dideoxyadenosine can also be used for anticancer purposes, where it has been shown to inhibit cancer cell growth.</p>

<p>Supplied as a 10mM solution (150uL).λmax 255 nm, ε 23.3 L mmol-1 cm-1Sold by weight of solid</p>

<p>2-Amino-9-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)purine is a novel nucleoside with anticancer and antiviral properties. It has been shown to inhibit replication of human immunodeficiency virus and herpes simplex virus type 1 in vitro. The drug also inhibits the growth of tumor cells in vitro. 2-Amino-9-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)purine is an analog of adenosine, which is phosphorylated by the enzyme ribonucleoside diphosphate kinase to form 2'-deoxyadenosine monophosphate, a common building block for DNA synthesis.</p>

<p>LDA is a technique for extracting spectral features from a set of spectra. It uses the probabilistic model of discriminant analysis to discriminate between groups of spectra. LDA has been shown to outperform other techniques, such as PCA and MDA, in analyzing datasets with a small number of variables. The algorithm is incrementally updated with new data points and parameters, which makes it an attractive choice for real-time applications.</p>

<p>N6-Benzoyl-7'-hydroxy-N-trityl morpholino adenine is a novel Ribonucleoside, which is a synthetic nucleoside with antiviral properties. It has been shown to inhibit the growth of cells in culture by inhibiting the synthesis of DNA and RNA. N6-Benzoyl-7'-hydroxy-N-trityl morpholino adenine has shown cytotoxicity against various cancer cells, including human leukemia cells, human lung cancer cells, and human breast cancer cells. The cytotoxic effects are thought to be due to inhibition of DNA synthesis and RNA synthesis.</p>

<p>2'-O-Methyluridine-5'-triphosphate lithium salt is a modified ribonucleoside which is used as an activator for nucleic acid synthesis. It has antiviral properties and can be used to inhibit the replication of DNA and RNA viruses. 2'-O-Methyluridine-5'-triphosphate lithium salt inhibits the viral polymerase, preventing the transcription of viral genetic material. This product is also considered novel because it is not found in nature and has not been previously described in the literature.</p>

<p>7-Chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidine is a palladium catalyst that catalyzes the cross-coupling reaction of aryl bromides and organoboronic acids with good efficiency. This method is an efficient and general procedure for the synthesis of various substituted pyrimidines. The cross-coupling reaction can be achieved in high yields without the need for purification of intermediates.</p>

<p>2',3'-O-Isopropylidene-adenosine-5-N-methylcarbamide is an activator that has anticancer and antiviral properties. It is a synthetic nucleoside, which is a modified form of the natural nucleosides adenosine and cytidine. 2',3'-O-Isopropylidene-adenosine-5-N-methylcarbamide inhibits the replication of DNA by binding to the deoxyribonucleoside triphosphate (dNTP) in DNA synthesis. The drug also inhibits viral RNA transcription by blocking the action of diphosphate reductase, an enzyme required for the conversion of ribonucleosides to ribonucleotides. 2',3'-O-Isopropylidene-adenosine-5-N-methylcarbamide has shown antiproliferative effects on human cancer cells in vitro and may be effective against leukemia and lymph</p>

<p>P1,P5-Di(adenosine-5')pentaphosphate trilithium salt is a diphosphate nucleoside that has antiviral and anticancer activities. It also inhibits DNA synthesis by competitively inhibiting the incorporation of dATP into DNA. This product is an activator of phosphoramidite chemistry. P1,P5-Di(adenosine-5')pentaphosphate trilithium salt is a novel monophosphate nucleoside with modified phosphorus linkages in the sugar backbone and a high purity of &gt; 98%.</p>

<p>P3-(1-(2-Nitrophenyl)ethyl) adenosine 5'-triphosphate disodium salt (P3-ANP-Na2) is an anticancer drug that belongs to the group of nucleosides. It is a phosphoramidate prodrug that is converted to adenosine 5'-triphosphate (ATP) by intracellular esterases. This prodrug has been shown to inhibit the growth of various types of cancer cells in vitro and in vivo, including leukemia and breast cancer cells. P3-ANP-Na2 binds to DNA by intercalation, inhibiting DNA synthesis and transcription. It also inhibits protein synthesis by inhibiting ribonucleotide reductase and deoxyribonucleotide reductase, which are enzymes responsible for synthesizing DNA precursors from RNA precursors.</p>

<p>5'-Deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine is a novel nucleoside phosphoramidite. It is synthesized by the reaction of 5'-deoxy-5-fluoro cytidine with 3-methylbutanol in the presence of an activator (e.g., tetrazole). The methyl group on the 3′ position of cytidine has been shown to improve antiviral activity, as well as DNA and RNA synthesis. The chemical purity of 5'-deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine is &gt;99% with no detectable impurities. This product is a white powder that is soluble in water and organic solvents.</p>

<p>Biotin-16-uridine-5'-triphosphate, lithium salt - 1 mM aqueous solution is a synthetic nucleotide that contains the natural nucleoside uridine and the modified nucleoside 5-biotin. It is an activator of DNA polymerase. Biotin-16-uridine-5'-triphosphate, lithium salt - 1 mM aqueous solution has antiviral properties as it inhibits HIV reverse transcriptase and human cytomegalovirus (HCMV) DNA polymerase. It also inhibits human telomerase activity by preventing telomeric DNA synthesis. The high purity of this product allows for its use in many different research applications.</p>

<p>3'-Azido-3'-deoxy-5-fluorocytidine is an activator with novel antiviral and anticancer properties. It is a high quality, modified nucleoside that can be used to synthesize deoxyribonucleosides and ribonucleosides. 3'-Azido-3'-deoxy-5-fluorocytidine has been shown to inhibit the growth of cancer cells in vitro and in vivo.</p>

<p>TFA-aa-dC is a novel anti-cancer drug that has been shown to have both antiviral and anticancer activities. It is a modified phosphoramidite of 2'-deoxyadenosine 5'-triphosphate with a 3'-amino group (TFA-aa-dC) and an acetyl group at the 2' position. TFA-aa-dC blocks viral replication by inhibiting the activity of viral DNA polymerase, which is required for DNA synthesis. The compound also inhibits cell growth by blocking RNA synthesis and protein production, leading to cell death. TFA-aa-dC has shown efficacy in preclinical studies against cervical cancer and leukemia cells.</p>

<p>3',5'-Diamino-3',5'-dideoxyadenosine (3,5-ddA) is a nucleoside that has been shown to be an efficient inhibitor of HIV replication in vitro. It has been used for the treatment of AIDS, but it is not yet approved for this use. 3,5-ddA inhibits the conversion of dATP to dTTP and prevents DNA synthesis by blocking the enzyme ribonucleotide reductase. The drug can be synthesized with high efficiency by using a modified nucleoside amidite approach.</p>

<p>N4-Acetyl-5'-O-DMT-cytidine 3'-succinyl CPG 1000 Å (RNA) is a novel, high quality, high purity, synthetic nucleoside analogue. It has antiviral and anticancer properties.</p>

<p>5-Bromopyrimidine-4,6(1H,5H)-dione is a novel nucleoside analogue. It can be used as an antiviral agent and an anticancer drug. It inhibits viral DNA replication by competitively binding to the viral DNA polymerase, thereby blocking the incorporation of deoxyribonucleotides into the growing DNA chain. 5-Bromopyrimidine-4,6(1H,5H)-dione also has antitumour activity. It has been shown to inhibit the growth of human cancer cells in vitro and in vivo.</p>

<p>3'-O-Azidomethyl 2'-deoxycytidine 5'-O-triphosphate sodium salt is a modified nucleoside that inhibits the synthesis of DNA. It has been shown to be an effective antiviral agent and can be used to treat cancer. 3'-O-Azidomethyl 2'-deoxycytidine 5'-O-triphosphate sodium salt is synthesized by reacting cytidine monophosphate with sodium azide in the presence of a triphosphorylating reagent. <br>3'-O-Azidomethyl 2'-deoxycytidine 5'-O-triphosphate sodium salt also inhibits DNA polymerase, which prevents the synthesis of RNA and proteins. The phosphoramidites are commercially available, high quality, and have a purity greater than 99%. This product is not currently approved by the FDA for use in humans or animals.</p>

<p>2’,3’-Bis-O-tert-butyldimethylsilyl-2-thiouridine is a modified nucleoside composed of 2-thiouracil (2-thiopyrimidine), a modified uracil where the oxygen at the 2-position is replaced by sulfur. Possible applications as its use as an intermediate in the chemical synthesis of RNA oligonucleotides.</p>

<p>6-Methylthioinosine-5’-triphosphate sodium salt - 10 mM aqueous solution is a synthetic, modified ribonucleoside that is an activator of the antiviral response. It has been shown to inhibit the replication of both DNA and RNA viruses in vitro. 6-Methylthioinosine-5’-triphosphate sodium salt - 10 mM aqueous solution is also used as a precursor in the synthesis of phosphoramidites. The CAS number for this product is 51464-82-5.</p>

<p>1,5-Anhydro-3-O-benzoyl-4,6-O-benzylidene-2-deoxy-2-(uracil-1-yl)-D-altrohexitol is a nucleoside that is used in the synthesis of DNA. It has antiviral and anticancer properties.</p>

<p>5'-O-DMT-guanosine-(dmf) 3'-succinyl CPG 500 Å (RNA) is a synthetic, modified nucleoside with the chemical name 5-O-dimethoxytrityl-guanine. It is a high purity and quality nucleoside that is synthesized from the corresponding ribonucleoside or deoxyribonucleoside by phosphoramidite chemistry. This compound has been shown to have anticancer and antiviral activity. The chemical formula for this compound is C14H12N4O8PS2, molecular weight of 692.5 g/mol, and CAS number 25608-06-0.</p>

<p>5'-O-tert-Butyldimethylsilylthymidine is a nucleoside that is used for the synthesis of oligoribonucleotides. It can be prepared by treating 5'-O-tert-butyldimethylsilylthymidine with alkyl bromides in the presence of microwaves and catalytic amounts of a base such as sodium methoxide. The product is purified by vacuum distillation or column chromatography and can be hydrolyzed to uridine, which has been shown to have anti-inflammatory properties. 5'-O-tert-Butyldimethylsilylthymidine can also be converted into deoxyribose through the use of ultrasound.</p>